Literature DB >> 24321817

Chronic obstructive pulmonary disease: important advances.

Peter J Barnes1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24321817     DOI： 10.1016/S2213-2600(12)70063-2

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  3 in total

1.  Cost-effective medicine vs. the medical-industrial complex.

Authors:  Lawrence Grouse
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

2.  Rapid Shallow Breathing Index Survey, a Predictor of non-Invasive Ventilation Necessity in Patients With Chronic Obstructive Pulmonary Disease Exacerbation: An Analytical Descriptive Prospective Study.

Authors:  Hassan Soleimanpour; Ali Taghizadieh; Rasoul Salimi; Samad Ej Golzari; Ata Mahmoodpoor; Saeid Safari; Robab Mehdizadeh Esfanjani; Yaghoub Heshmat
Journal:  Iran Red Crescent Med J       Date:  2014-02-09       Impact factor: 0.611

3.  Losartan does not inhibit cigarette smoke-induced lung inflammation in mice.

Authors:  M L Hepworth; S L Passey; H J Seow; R Vlahos
Journal:  Sci Rep       Date:  2019-10-21       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.